The medicines regulator, Swissmedic, has given the go ahead to the one-shot vaccine from the US company Johnson and Johnson.
Sometimes known as the Janssen Vaccine, it has a 66.9% efficacy rate in those over 18 years old.
The drug was put forward for authorisation in December.
The vaccine has been used in the United States since February.
As yet, there’s no information when it will start to be used.
Heat closes Geneva paddling pools
Soaring temps hit hospitals
Crans-Montana looks to summer season after fire tragedy
MétéoSuisse warns of budget cuts
Rents rise Geneva - more than Zurich
Better passenger rights coming
